NCT05003440View on ClinicalTrials.gov

A Research Study Looking at How the Medicine NNC0385-0434 Works in the Body of Healthy Japanese Men

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

August 19, 2021

Primary Completion Date

January 19, 2022

Study Completion Date

January 19, 2022

Conditions
Healthy VolunteersAtherosclerotic Cardiovascular Disease
Interventions
DRUG

NNC0385-0434

Participants will get 1 tablet (oral use) of NNC0385-0434 per day for 10 days in either 15, 40 or 100 mg

DRUG

Placebo

Participants will get 1 tablet (oral use) of placebo per day for 10 days

Trial Locations (1)

812-0025

Hakata Clinic, Fukuoka

Sponsors

Lead Sponsor

Novo Nordisk A/S
All Listed Sponsors
lead

Novo Nordisk A/S

INDUSTRY